Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initial vs Delayed PDT with Conbercept for PCV
NCT02821520Phase 4Completed
- Sponsor
- Eye Hospital of Wenzhou Medical University
- Start
- Jan 2017
- Primary completion
- Jun 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of conbercept in polypoidal choroidal vasculopathy (PCV), sponsored by Eye Hospital of Wenzhou Medical University. Started Jan 2017; status: completed.
02
Drugs
conbercept
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT02821520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02821520.